Compare SIRI & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIRI | IBRX |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 7.5B |
| IPO Year | 1996 | 2015 |
| Metric | SIRI | IBRX |
|---|---|---|
| Price | $23.74 | $7.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $25.00 | $12.57 |
| AVG Volume (30 Days) | 3.2M | ★ 21.1M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.52% | N/A |
| EPS Growth | ★ 136.32 | 38.71 |
| EPS | ★ 2.23 | N/A |
| Revenue | ★ $5,425,129,000.00 | $113,288,000.00 |
| Revenue This Year | $1.81 | $88.59 |
| Revenue Next Year | $0.67 | $131.15 |
| P/E Ratio | $10.71 | ★ N/A |
| Revenue Growth | 8.13 | ★ 668.31 |
| 52 Week Low | $19.41 | $1.83 |
| 52 Week High | $24.55 | $12.43 |
| Indicator | SIRI | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 63.69 | 49.62 |
| Support Level | $22.76 | $2.25 |
| Resistance Level | $24.45 | $8.28 |
| Average True Range (ATR) | 0.53 | 0.63 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 75.12 | 53.23 |
SiriusXM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service via a fleet of geostationary satellites it owns and operates, and now offers a streaming SiriusXM option. Pandora, which accounts for a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants such as Spotify, Apple Music, and YouTube Music.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.